Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Germany: reliable data on MS incidence available from 2-year study:

This article was originally published in Clinica

Executive Summary

The German population of multiple sclerosis sufferers is currently 120,000, with 2,500 new cases recorded every year. The economic costs are some euro500m ($585m) per year in direct hospital costs and a further euro3.5bn in social benefits and other costs. A study led by Dr Peter Flachenecker, of the university hospital of Wurzburg set out to log patients at five regional centres over a two-year period, ending in December 2003. Their documentation project covered some 3,400 patients during this period allowing them to calculate new incidence as being 3 per 100,000 of population (based on observations in Rostock and Wurzburg). Newly-diagnosed MS patients were on average 30 years old. The project also revealed that two-thirds of observed patients were female; a third had limited mobility; 7% were wheelchair-bound; 1.6% were bed-bound. The register has since grown to 10,000 cases, and neurologists hope the knowledge put into this developing database will help in the management and therapy of patients.

You may also be interested in...



Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT050745

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel